349 related articles for article (PubMed ID: 30414936)
1. From bench to bedside, via desktop. Recent advances in the application of cutting-edge in silico tools in the research of drugs targeting bromodomain modules.
Myrianthopoulos V; Mikros E
Biochem Pharmacol; 2019 Jan; 159():40-51. PubMed ID: 30414936
[TBL] [Abstract][Full Text] [Related]
2. Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations.
Cournia Z; Allen B; Sherman W
J Chem Inf Model; 2017 Dec; 57(12):2911-2937. PubMed ID: 29243483
[TBL] [Abstract][Full Text] [Related]
3. Hybrid schemes based on quantum mechanics/molecular mechanics simulations goals to success, problems, and perspectives.
Ferrer S; Ruiz-Pernía J; Martí S; Moliner V; Tuñón I; Bertrán J; Andrés J
Adv Protein Chem Struct Biol; 2011; 85():81-142. PubMed ID: 21920322
[TBL] [Abstract][Full Text] [Related]
4. A molecular-modeling toolbox aimed at bridging the gap between medicinal chemistry and computational sciences.
Eid S; Zalewski A; Smieško M; Ernst B; Vedani A
Int J Mol Sci; 2013 Jan; 14(1):684-700. PubMed ID: 23344039
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
Honório KM; Moda TL; Andricopulo AD
Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
[TBL] [Abstract][Full Text] [Related]
6. Computational Methodologies in the Exploration of Marine Natural Product Leads.
Pereira F; Aires-de-Sousa J
Mar Drugs; 2018 Jul; 16(7):. PubMed ID: 30011882
[TBL] [Abstract][Full Text] [Related]
7. Application of Multiscale Simulation Tools on GPCRs. An Example with Angiotensin II Type 1 Receptor.
Erol I; Aksoydan B; Kantarcioglu I; Durdagi S
Methods Mol Biol; 2018; 1824():431-448. PubMed ID: 30039423
[TBL] [Abstract][Full Text] [Related]
8. Advancing Drug Discovery through Enhanced Free Energy Calculations.
Abel R; Wang L; Harder ED; Berne BJ; Friesner RA
Acc Chem Res; 2017 Jul; 50(7):1625-1632. PubMed ID: 28677954
[TBL] [Abstract][Full Text] [Related]
9. Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology.
Galdeano C; Ciulli A
Future Med Chem; 2016 Sep; 8(13):1655-80. PubMed ID: 27193077
[TBL] [Abstract][Full Text] [Related]
10. Investigating drug-target association and dissociation mechanisms using metadynamics-based algorithms.
Cavalli A; Spitaleri A; Saladino G; Gervasio FL
Acc Chem Res; 2015 Feb; 48(2):277-85. PubMed ID: 25496113
[TBL] [Abstract][Full Text] [Related]
11. User-Friendly Quantum Mechanics: Applications for Drug Discovery.
Kotev M; Sarrat L; Gonzalez CD
Methods Mol Biol; 2020; 2114():231-255. PubMed ID: 32016897
[TBL] [Abstract][Full Text] [Related]
12. Physics-based scoring of protein-ligand interactions: explicit polarizability, quantum mechanics and free energies.
Bryce RA
Future Med Chem; 2011 Apr; 3(6):683-98. PubMed ID: 21554075
[TBL] [Abstract][Full Text] [Related]
13. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
14. Absolute Alchemical Free Energy Calculations for Ligand Binding: A Beginner's Guide.
Aldeghi M; Bluck JP; Biggin PC
Methods Mol Biol; 2018; 1762():199-232. PubMed ID: 29594774
[TBL] [Abstract][Full Text] [Related]
15. QSAR Methods.
Gini G
Methods Mol Biol; 2016; 1425():1-20. PubMed ID: 27311459
[TBL] [Abstract][Full Text] [Related]
16. Mind the Gap! A Journey towards Computational Toxicology.
Mangiatordi GF; Alberga D; Altomare CD; Carotti A; Catto M; Cellamare S; Gadaleta D; Lattanzi G; Leonetti F; Pisani L; Stefanachi A; Trisciuzzi D; Nicolotti O
Mol Inform; 2016 Sep; 35(8-9):294-308. PubMed ID: 27546034
[TBL] [Abstract][Full Text] [Related]
17. Rapid and Reliable Binding Affinity Prediction of Bromodomain Inhibitors: A Computational Study.
Wan S; Bhati AP; Zasada SJ; Wall I; Green D; Bamborough P; Coveney PV
J Chem Theory Comput; 2017 Feb; 13(2):784-795. PubMed ID: 28005370
[TBL] [Abstract][Full Text] [Related]
18. In silico study directed towards identification of novel high-affinity inhibitors targeting an oncogenic protein: BRD4-BD1.
Tumdam R; Kumar A; Subbarao N; Balaji BS
SAR QSAR Environ Res; 2018 Dec; 29(12):975-996. PubMed ID: 30411639
[TBL] [Abstract][Full Text] [Related]
19. Understanding the impact of binding free energy and kinetics calculations in modern drug discovery.
Adediwura VA; Koirala K; Do HN; Wang J; Miao Y
Expert Opin Drug Discov; 2024 Jun; 19(6):671-682. PubMed ID: 38722032
[TBL] [Abstract][Full Text] [Related]
20. Computational tools for polypharmacology and repurposing.
Achenbach J; Tiikkainen P; Franke L; Proschak E
Future Med Chem; 2011 Jun; 3(8):961-8. PubMed ID: 21707399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
